1. Home
  2. DLPN vs AYTU Comparison

DLPN vs AYTU Comparison

Compare DLPN & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DLPN
  • AYTU
  • Stock Information
  • Founded
  • DLPN 1996
  • AYTU N/A
  • Country
  • DLPN United States
  • AYTU United States
  • Employees
  • DLPN N/A
  • AYTU N/A
  • Industry
  • DLPN Other Consumer Services
  • AYTU Biotechnology: Pharmaceutical Preparations
  • Sector
  • DLPN Consumer Discretionary
  • AYTU Health Care
  • Exchange
  • DLPN Nasdaq
  • AYTU Nasdaq
  • Market Cap
  • DLPN 21.8M
  • AYTU 23.0M
  • IPO Year
  • DLPN N/A
  • AYTU N/A
  • Fundamental
  • Price
  • DLPN $1.59
  • AYTU $2.10
  • Analyst Decision
  • DLPN Strong Buy
  • AYTU Strong Buy
  • Analyst Count
  • DLPN 1
  • AYTU 3
  • Target Price
  • DLPN $5.00
  • AYTU $9.17
  • AVG Volume (30 Days)
  • DLPN 42.7K
  • AYTU 78.4K
  • Earning Date
  • DLPN 11-12-2025
  • AYTU 11-13-2025
  • Dividend Yield
  • DLPN N/A
  • AYTU N/A
  • EPS Growth
  • DLPN N/A
  • AYTU N/A
  • EPS
  • DLPN N/A
  • AYTU N/A
  • Revenue
  • DLPN $51,257,243.00
  • AYTU $66,382,000.00
  • Revenue This Year
  • DLPN $9.05
  • AYTU N/A
  • Revenue Next Year
  • DLPN $15.42
  • AYTU $29.12
  • P/E Ratio
  • DLPN N/A
  • AYTU N/A
  • Revenue Growth
  • DLPN 4.84
  • AYTU 1.84
  • 52 Week Low
  • DLPN $0.75
  • AYTU $0.95
  • 52 Week High
  • DLPN $1.88
  • AYTU $2.82
  • Technical
  • Relative Strength Index (RSI)
  • DLPN 49.69
  • AYTU 42.34
  • Support Level
  • DLPN $1.43
  • AYTU $2.01
  • Resistance Level
  • DLPN $1.79
  • AYTU $2.21
  • Average True Range (ATR)
  • DLPN 0.14
  • AYTU 0.14
  • MACD
  • DLPN -0.03
  • AYTU -0.02
  • Stochastic Oscillator
  • DLPN 29.78
  • AYTU 53.77

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: